Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Bivas Biswas's publication output changed over time?
ScholarIQpublication output · 2014–2025
Output declined75% over the shown period — from 4 works in 2014 to 1 in 2025.
4
1
2
3
1
20142016202020232025
What are the most-cited papers on Bivas Biswas?
ScholarIQmost cited works
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
John V. Heymach, David H. Harpole, Tetsuya Mitsudomi, Janis M. Taube, Gabriella Gálffy, Maximilian J. Hochmair, Thomas Winder, Р. А. Зуков, Gabriel Garbaos, Shugeng Gao, Hiroaki Kuroda, Gyula Ostoros, Tho V. Tran, Jian You, Kang‐Yun Lee, Lorenzo Antonuzzo, Zsolt Pápai-Székely, Hiroaki Akamatsu, Bivas Biswas, Alexander I. Spira, Jeffrey Crawford, Ha Le, Mike Aperghis, Gary J. Doherty, Helen Mann, Tamer M. Fouad, Martin Reck
New England Journal of Medicine. 2023724 CitationsOPEN ACCESS
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Pasi A. Jänne, David Planchard, Kunihiko Kobayashi, James Chih‐Hsin Yang, Ying L. Liu, Natalia Valdiviezo, Tae Min Kim, Liyan Jiang, Hiroshi Kagamu, Noriko Yanagitani, Jialei Wang, Bivas Biswas, Artem Poltoratskiy, Yeni Nerón, Carlos A. Rojas, Leona Koubková, Carles Escriu, Doreen A. Ezeife, Helen Mann, Elena Armenteros-Monterroso, Yuri Rukazenkov, Chee Khoon Lee
New England Journal of Medicine. 202580 Citations
Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma
Bivas Biswas, N. K. Shukla, S. V. S. Deo, Sandeep Agarwala, D.N. Sharma, Sreenivas Vishnubhatla, Sameer Bakhshi
Pediatric Blood & Cancer. 201469 Citations
Management of Ewing sarcoma family of tumors: Current scenario and unmet need
Bivas Biswas, Sameer Bakhshi
S2764860420. 201657 CitationsOPEN ACCESS
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
Ullas Batra, Bivas Biswas, Kumar Prabhash, M. Vamshi Krishna
S2736820664. 202355 CitationsOPEN ACCESS
Related on ScholarIQ
Apollo Gleneagles Hospitals
Institution
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Paper
Survival with Osimertinib plus Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Paper
Evaluation of outcome and prognostic factors in extraosseous Ewing sarcoma
Paper
Management of Ewing sarcoma family of tumors: Current scenario and unmet need
Paper
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
Paper